|
Sign In to gain access to subscriptions and/or personal tools.
|
Death by tricyclic: the real antidepressant scandal?
David J. Nutt
University of Bristol, Psychopharmacology Unit, Dorothy Hodgkin Building, Bristol, UK, david.j.nutt{at}bristol.ac.uk
References
- British National Formulary (BNF) 48, September 2004
- Crombie I K (1990) Suicide in England and Wales and in Scotland. An examination of divergent trends . Br J Psychiatry 157: 529-532 [Abstract/Free Full Text]
- DOH (2004) www.dh.gov.uk
- FDA (Jan 2005) www.fda.gov
- Goodwin G M (2004) Conflict of interest is not just about advising pharmaceutical companies . J Psychopharmacol 18: 447-448 [Free Full Text]
- Hazell P (2002) Depression in children . BMJ 325: 229-230 [Free Full Text]
- Isacsson G (2000) Suicide prevention - a medical breakthrough? Acta Psychiatr Scand 102: 113-117 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jonsson B, Bebbington P E (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment . Br J Psychiatry 164: 665-673 [Abstract/Free Full Text]
- NICE (2004) The treatment of depression www.nice.org.uk
- Nutt D J (2003) Death and dependence: current controversies over the selective serotonin reuptake inhibitors . J Psychopharmacol 17: 355-364 [Abstract/Free Full Text]
- Office of National Statistics (2004a) Fatal toxicity of antidepressants in England and Wales 1993-2002 . Health Stat Quart 23: 18-24
- Office of National Statistics (2004b) Deaths related to drug poisoning: England and Wales 1998-2002 . Health Stat Quart 21: 59-66
- Schapira K, Linsley K R, Linsley A, Kelly T P, Kay D W (2001) Relationship of suicide rates to social factors and availability of lethal methods: comparison of suicide in Newcastle upon Tyne 1961-1965 and 1985-1994 . Br J Psychiatry 178: 458-464 [Abstract/Free Full Text]
- SIGN (Jan 2005) www.sign.ac.uk
- Treatment for Adolescents with Depression study team (TADS) (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression . JAMA 292: 807-820 [Abstract/Free Full Text]
Journal of Psychopharmacology, Vol. 19, No. 2,
123-124 (2005)
DOI: 10.1177/0269881105051987
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J Deakin and C O'Loughlin
STAR*D: a summary and UK perspective
J Psychopharmacol,
August 1, 2009;
23(6):
605 - 612.
[PDF]
|
|
|
|
|
|
|
S. Wilson and D. Nutt
Drug treatment of chronic insomnia -- dawn at the end of a long night?
J Psychopharmacol,
September 1, 2008;
22(7):
703 - 706.
[PDF]
|
|
|
|
|
|
|
P. Blier and D. Nutt
Reply from the Editors
J Psychopharmacol,
August 1, 2007;
21(6):
670 - 670.
[PDF]
|
|
|
|
|
|
|
P. Blier
Media pressure and patient care
J Psychopharmacol,
July 1, 2006;
20(4):
469 - 470.
[PDF]
|
|
|
|
|
|
|
J. Luty, C. O'Gara, and M. Sessay
Is methadone too dangerous for opiate addiction?
BMJ,
December 10, 2005;
331(7529):
1352 - 1353.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
November 1, 2005;
19(6):
567 - 596.
[Abstract]
[PDF]
|
|
|
|
|
